Q8NB16 (MLKL_HUMAN) Homo sapiens (Human)
Mixed lineage kinase domain-like protein UniProtKBInterProSTRINGInteractive Modelling
471 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
22 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Structure of monobody 32 human MLKL pseudokinase domain complex |
Heteromer | 100 | 2×EDO; | |||
| Structure of monobody 27 human MLKL pseudokinase domain complex |
Heteromer | 100.0 | ||||
| Structure of human RIPK3-MLKL complex |
Heteromer Q9Y572; | 100.0 | 2×ZL1; | |||
| Structure of monobody 33 MLKL N-terminal domain complex |
Heteromer | 100 | 4×ZN; | |||
| Crystal structure of phosphorylated (T357/S358) human MLKL pseudokinase domain | homo-2-mer | 100.0 | ||||
| Crystal Structure of the human MLKL pseudokinase domain bound to compound 2 | monomer | 100.0 | 4×EDO; | |||
| Pseudokinase Domain of MLKL bound to Compound 4. | monomer | 100.0 | 1×6UY; | |||
| MLKL mutant - T357AS358A | monomer | 100.0 | ||||
| MLKL mutant - T357ES358D | monomer | 100.0 | ||||
| Crystal structure of the human MLKL pseudokinase domain T357E/S358E mutant | monomer | 100.0 | 4×GOL; | |||
| Crystal structure of the human MLKL pseudokinase domain | monomer | 100.0 | 1×PXN; 1×GOL; | |||
| Crystal structure of the human MLKL kinase-like domain | monomer | 100.0 | ||||
| Pseudokinase Domain of MLKL bound to Compound 1. | monomer | 100.0 | 1×6UX; | |||
| Direct Activation of the Executioner Domain of MLKL by a Select Repertoire of Inositol Phosphates | monomer | 100 | ||||
| Solution structure of the MLKL N-terminal domain | monomer | 99.35 | ||||
| Solution structure of MLKL executioner domain in complex with a covalent inhibitor | monomer | 100 | 1×QOK; | |||
| Solution structure of MLKL executioner domain in complex with a fragment | monomer | 100 | 1×UJ2; | |||
| Solution structure of MLKL executioner domain in complex with a fragment | monomer | 100 | 1×UJ5; | |||
| Solution structure of MLKL executioner domain in complex with a fragment | monomer | 100 | 1×UJ8; | |||
| Solution structure of unliganded MLKL executioner domain | monomer | 100 | ||||
| Crystal structure of MLKL executioner domain in complex with a covalent inhibitor | monomer | 100.0 | 1×QOK; | |||
| Crystal structure of unliganded MLKL executioner domain | monomer | 100.0 | 1×CL; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6lk5.1.A | monomer | 0.80 | 99.58 | |||
2 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 6zle.1.A | monomer | 0.69 | 100.00 | |||
| Isoform 2 | 7jxu.2.A | monomer | 0.64 | 98.31 | |||